Zydus Lifesciences added 1.77% to Rs 979.05 after the firm informed that its Ahmedabad API facility has been allowed to commercially manufacture and supply the API (active pharmaceutical ingredient) by the US drug regulator.
| Subscribe To Our Free Newsletter |
